Shanghai Haohai Biological Technology Co., Ltd. (SEHK:6826) commences share repurchases on September 26, 2023, under the program mandated by shareholders in the Extraordinary General Meeting held on September 15, 2023. As per the mandate, the company is authorized to repurchase up to 1,538,461 shares, representing 0.9% of its share capital for CNY 200 million. The shares will be repurchased at a price not more than CNY 130 per share.

The repurchased shares will be used for equity incentive and/or employee shareholding plan. If the company fails to utilize shares for the said purpose within three years after the publication of the announcement on the results of the Share Repurchase and shareholding changes, the A Shares repurchased under the Repurchase Plan remained unused will be cancelled pursuant to the applicable laws. The authorization will be valid for 12 months.

As of August 28, 2023, the company had 171,287,974 Shares comprising 32,895,100 H Shares and 138,392,874 A Shares.